For instance, ESE1 is reported to negatively regulate EMT in bladder and ovarian cancer cells,12, 13 whereas in non‐small cell lung cancer (NSCLC)14 and hepatocellular cancer (HCC),15 it promotes cell proliferation and EMT. This evidence concerns the gene ELF3 and hepatocellular carcinoma.